Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25287828

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Nov 1
First author
Guimbaud R

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):684. doi: 10.1038/nrclinonc.2014.184.
    note
    Source null
    related pmid
    25331178
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Apr 20;33(12):1416. doi: 10.1200/jco.2015.61.9759.
    note
    Source null
    related pmid
    25883365
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2015 Jul 20;33(21):2410-1. doi: 10.1200/JCO.2014.60.5550.
    note
    Source null
    related pmid
    26077234
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2015 Jul 20;33(21):2410. doi: 10.1200/JCO.2014.59.8847.
    note
    Source null
    related pmid
    26077236
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2015 Jul 20;33(21):2409. doi: 10.1200/JCO.2014.59.7088.
    note
    Source null
    related pmid
    26077239
    relationship
    Comment in

Authors and identifiers

  1. name
    Guimbaud R
    type
    Author
  2. name
    Louvet C
    type
    Author
  3. name
    Ries P
    type
    Author
  4. name
    Ychou M
    type
    Author
  5. name
    Maillard E
    type
    Author
  6. name
    André T
    type
    Author
  7. name
    Gornet JM
    type
    Author
  8. name
    Aparicio T
    type
    Author
  9. name
    Nguyen S
    type
    Author
  10. name
    Azzedine A
    type
    Author
  11. name
    Etienne PL
    type
    Author
  12. name
    Boucher E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Guimbaud R
    type
    Author
  2. name
    Louvet C
    type
    Author
  3. name
    Ries P
    type
    Author
  4. name
    Ychou M
    type
    Author
  5. name
    Maillard E
    type
    Author
  6. name
    André T
    type
    Author
  7. name
    Gornet JM
    type
    Author
  8. name
    Aparicio T
    type
    Author
  9. name
    Nguyen S
    type
    Author
  10. name
    Azzedine A
    type
    Author
  11. name
    Etienne PL
    type
    Author
  12. name
    Boucher E
    type
    Author
bibliography ids
  1. nci-bib-c44c673c60abeb6ec738f1c4
book metadata
content sha256
8945ac380766f59fddc6b70f9456e39d6aec1543f8febc450775037c3e2e903e
document type
citation
dois
  1. 10.1200/JCO.2013.54.1011
electronic publication date
display
2014 Oct 6
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25287828
immutable id
pubmed:25287828@8945ac380766f59fddc6b70f9456e39d6aec1543f8febc450775037c3e2e903e
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3520-6
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2014 Dec;11(12):684. doi: 10.1038/nrclinonc.2014.184.
    note
    Source null
    related pmid
    25331178
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Apr 20;33(12):1416. doi: 10.1200/jco.2015.61.9759.
    note
    Source null
    related pmid
    25883365
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2015 Jul 20;33(21):2410-1. doi: 10.1200/JCO.2014.60.5550.
    note
    Source null
    related pmid
    26077234
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2015 Jul 20;33(21):2410. doi: 10.1200/JCO.2014.59.8847.
    note
    Source null
    related pmid
    26077236
    relationship
    Comment in
  5. citation
    J Clin Oncol. 2015 Jul 20;33(21):2409. doi: 10.1200/JCO.2014.59.7088.
    note
    Source null
    related pmid
    26077239
    relationship
    Comment in
outcomes validated
false
pmid
25287828
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
67d41ad5a47c153beda1d1b1f4745ea8c674d331d0c347d814426e7e22ca1952
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Nov 1
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25287828/
title
Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.

Preserved source evidence · Not medical advice